STARTING YOUR PATIENTS ON KESIMPTA
Life with RMS is complicated, starting treatment shouldn't be
Getting patients started on KESIMPTA

SCREEN
Bloodwork to screen patients
for
HBV and test their Ig levels1

SHOW
Demonstrate KESIMPTA administration
using the Sensoready® Demo Pen

START
Start today with samples.*
Submit 1-page Start Form
We'll automatically enroll your patient in Alongside™ KESIMPTA for support and assistance throughout their first year on treatment.
-
HBV and Ig testing can be added to your patient's regular blood panels
-
Training pens and videos are provided by Novartis. We can also provide supplemental one-on-one training for your patient virtually or at home
-
Before initiating KESIMPTA, discuss treatment, including possible side effects like injection reactions, and explain to patients that they start with 1 dose a week for the first 3 weeks, then skip the 4th week before starting once-monthly maintenance dosing
-
Patients can visit KESIMPTA.com for more details, and may also self-enroll in our Alongside program from the patient site
*Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA.
Patient resources
Novartis is committed to providing patients with access to medication regardless of their ability to pay. Below you'll find the materials and forms you may need to help your patients get started on KESIMPTA.
For your patients
Resources to help your patients with RMS prepare to use KESIMPTA
Personalized support for your patients to start and stay on track with treatment
-
Dedicated Alongside KESIMPTA Coordinators tailor support so patients are prepared, not overwhelmed
-
See what else we can help with on the Alongside KESIMPTA page
Patient injection training
See how patients learn to use the Sensoready Pen
See patient-friendly live action tips for injection with the pen

Ensure that your patients are getting the coverage and support they need.
Call 1-855-537-46781-855-537-4678 for assistance or questions about how to enroll your patients in Alongside KESIMPTA. Support is available 8:30 AM to 8:00 PM ET, Mon-Fri.
KESIMPTA right away.
Kristin: mom, real estate agent, KESIMPTA patient†


†Actual KESIMPTA patient who was compensated for their time. Individual results may vary.
Support for your practice
Everything you need to start patients quickly

Start today with samples
KESIMPTA offers a free trial through
its sample program to get
patients
started today*

5 days to bridge product
80% of commercial patients
receive their first bridge dose in
5 days2
Based on prescription and dispense data as of
November 2022.

92% coverage
The vast majority of commercial
lives covered on KESIMPTA3†
*Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA.
†Based on unrestricted or single-step edit coverage. Example based on prescription data as of September 2021.
Resources to help make KESIMPTA part of your practice

See our educational videos
about
KESIMPTA and the
Sensoready Pen
Visit the KESIMPTA Video Library

Templates to help navigate insurance coverage
Visit patient site

Information and resources for treatment with KESIMPTA are available directly to patients. View the KESIMPTA patient site and learn more about these helpful patient services.


assisting with insurance questions to providing
supplemental training on the Sensoready Pen.
Leticia, Alongside Coordinator


program
Start patients on KESIMPTA today
DOWNLOAD START FORMSubmit a Start Form by fax or online at CoverMyMeds®
VISIT COVERMYMEDS®HBV=hepatitis B virus; Ig=immunoglobulin; MOA=mechanism of action; RMS=relapsing multiple sclerosis.
References: 1. Kesimpta [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp. 2. Data on file. Program data. Novartis Pharmaceuticals Corp; East Hanover, NJ. November 2022. 3. Data on file. Market access. Novartis Pharmaceuticals Corp; East Hanover, NJ. September 2021.